ETON
Eton Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
ETON fundamentals
During Q4 2025, Eton Pharmaceuticals (ETON) reported revenue of 21.28M, a YoY change of 82.72%. Net income was 1.48M, a YoY change of 347.99%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | TTM |
|---|
Start Date | Jul 1, 2017 | Oct 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2018 | Oct 1, 2018 | Jan 1, 2019 | Apr 1, 2019 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Sep 30, 2017 | Dec 31, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2018 | Dec 31, 2018 | Mar 31, 2019 | Jun 30, 2019 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 500.00K -- | -- -- | -- -- | 459.00K -- | 99.00K -80.20% | 20.00K -- | -161.00K -- | 81.00K -82.35% | 11.90M +11917.17% | 3.07M +15235.00% | 775.00K +581.37% | 6.09M +7422.22% | 2.18M -81.71% | 7.36M +139.91% | 3.22M +315.35% | 8.50M +39.47% | 5.30M +143.75% | 12.00M +63.05% | 7.03M +118.33% | 7.31M -13.94% | 7.97M +50.19% | 9.07M -24.36% | 10.32M +46.90% | 11.65M +59.26% | 17.28M +116.95% | 18.93M +108.60% | 22.46M +117.54% | 21.28M +82.72% | 79.95M -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 500.00K -- | -- -- | -- -- | 459.00K -- | 99.00K -80.20% | 20.00K -- | -161.00K -- | 81.00K -82.35% | 11.90M +11917.17% | 3.07M +15235.00% | 775.00K +581.37% | 6.09M +7422.22% | 2.18M -81.71% | 7.36M +139.91% | 3.22M +315.35% | 8.50M +39.47% | 5.30M +143.75% | 12.00M +63.05% | 7.03M +118.33% | 7.31M -13.94% | 7.97M +50.19% | 9.07M -24.36% | 10.32M +46.90% | 11.65M +59.26% | 17.28M +116.95% | 18.93M +108.60% | 22.46M +117.54% | 21.28M +82.72% | 79.95M -- |
Cost of Revenue | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 453.00K -- | 102.00K -- | 28.00K -- | -144.00K -- | 450.00K -0.66% | 1.59M +1458.82% | 174.00K +521.43% | 654.00K +554.17% | 372.00K -17.33% | 849.00K -46.60% | 2.75M +1477.59% | 1.20M +83.64% | 2.14M +474.73% | 1.96M +130.62% | 2.31M -15.66% | 2.63M +118.57% | 3.68M +72.26% | 2.96M +51.12% | 3.45M +48.94% | 4.02M +53.22% | 5.17M +40.40% | 7.42M +150.79% | 7.00M +103.13% | 14.60M +263.10% | 8.18M +58.21% | 37.21M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 436.00K -- | -- -- | -- -- | -- -- | 2.83M +548.39% | -- -- | -- -- | -- -- | 6.93M +145.24% | -- -- | -- -- | 2.63M -- | 3.68M -46.88% | 2.96M -- | 3.45M -- | 4.02M +53.22% | 5.17M +40.40% | 7.42M +150.79% | 7.00M +103.13% | 14.60M +263.10% | 8.18M +58.21% | 37.21M -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 500.00K -- | -- -- | -- -- | 6.00K -- | -3.00K -100.60% | -8.00K -- | -17.00K -- | -369.00K -6250.00% | 10.31M +343666.67% | 2.89M +36262.50% | 121.00K +811.76% | 5.72M +1650.41% | 1.33M -87.13% | 4.61M +59.45% | 2.02M +1567.77% | 6.36M +11.17% | 3.35M +152.15% | 9.68M +109.89% | 4.40M +118.19% | 3.63M -42.92% | 5.01M +49.64% | 5.63M -41.89% | 6.30M +43.13% | 6.48M +78.40% | 9.86M +96.94% | 11.92M +111.94% | 7.86M +24.64% | 13.10M +102.29% | 42.74M -- |
Operating Expenses | 2.77M -- | 2.20M -- | 2.96M -- | 2.70M -- | 2.37M -14.30% | 2.29M +4.10% | 8.05M +171.73% | 3.35M +24.18% | 5.04M +112.38% | 2.66M +16.45% | 8.88M +10.23% | 4.53M +35.26% | 6.25M +24.06% | 7.05M +164.88% | 4.94M -44.31% | 5.22M +15.19% | 5.97M -4.59% | 4.41M -37.50% | 6.41M +29.73% | 5.95M +14.09% | 4.91M -17.68% | 5.30M +20.22% | 5.88M -8.33% | 5.80M -2.59% | 4.95M +0.77% | 5.62M +6.13% | 5.81M -1.24% | 8.56M +47.63% | 5.79M +17.01% | 5.85M +3.98% | 10.33M +77.91% | 13.40M +56.51% | 9.22M +59.12% | 10.64M +81.91% | 43.58M -- |
Selling, General and Administrative Expenses | 1.21M -- | 1.33M -- | 1.69M -- | 990.00K -- | 830.00K -31.18% | 1.18M -11.18% | 1.59M -5.98% | 1.91M +92.93% | 1.62M +95.66% | 2.43M +105.15% | 2.61M +64.25% | 2.92M +52.93% | 3.43M +111.15% | 3.65M +50.27% | 4.06M +55.48% | 3.23M +10.51% | 3.29M -4.05% | 3.73M +2.08% | 4.80M +18.19% | 5.26M +63.04% | 4.17M +26.72% | 4.35M +16.85% | 5.34M +11.45% | 4.67M -11.19% | 4.34M +4.01% | 4.58M +5.10% | 5.16M -3.54% | 5.59M +19.62% | 5.29M +21.96% | 6.72M +46.81% | 9.17M +77.85% | 9.69M +73.26% | 8.11M +53.29% | 8.86M +31.82% | 35.82M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 12.61M -- | -- -- | -- -- | -- -- | 14.27M +13.12% | -- -- | -- -- | -- -- | 18.58M +30.26% | -- -- | -- -- | 4.34M -- | 4.58M -75.37% | 5.16M -- | 5.59M -- | 5.29M +21.96% | 6.72M +46.81% | 9.17M +77.85% | 9.69M +73.26% | 8.11M +53.29% | 8.86M +31.82% | 35.82M -- |
Research and Development Expenses | 1.56M -- | 863.00K -- | 1.27M -- | 1.71M -- | 1.54M -1.28% | 1.10M +27.69% | 6.46M +407.46% | 1.44M -15.70% | 3.42M +121.37% | 233.00K -78.86% | 6.27M -3.05% | 1.61M +11.81% | 2.83M -17.32% | 3.40M +1359.66% | 886.00K -85.86% | 1.99M +23.68% | 2.68M -5.24% | 681.00K -79.98% | 1.62M +82.62% | 690.00K -65.33% | 744.00K -72.22% | 944.00K +38.62% | 535.00K -66.93% | 1.13M +63.04% | 615.00K -17.34% | 1.05M +10.91% | 651.00K +21.68% | 2.97M +164.00% | 505.00K -17.89% | -871.00K -183.19% | 1.16M +78.34% | 3.71M +24.98% | 1.11M +120.20% | 1.78M +304.36% | 7.76M -- |
Operating Income | -2.77M -- | -2.20M -- | -2.96M -- | -2.70M -- | -2.37M +14.30% | -2.29M -4.10% | -7.55M -154.86% | -3.35M -24.18% | -5.04M -112.38% | -2.66M -16.19% | -8.88M -17.57% | -4.54M -35.50% | -6.27M -24.40% | -7.42M -179.37% | 5.36M +160.39% | -2.33M +48.77% | -5.85M +6.78% | 1.31M +117.71% | -5.09M -194.85% | -1.34M +42.37% | -2.90M +50.49% | 1.06M -19.18% | -2.53M +50.19% | 3.88M +389.78% | -548.00K +81.07% | -1.99M -287.66% | -800.00K +68.43% | -2.94M -175.59% | 509.00K +192.88% | 629.00K +131.56% | -470.00K +41.25% | -1.48M +49.74% | -1.36M -367.78% | 2.46M +291.73% | -844.00K -- |
Non-Operating Income (Loss) | -32.00K -- | 26.00K -- | -54.00K -- | -385.00K -- | -536.00K -1575.00% | -1.44M -5653.85% | 144.00K +366.67% | 100.00K +125.97% | 77.00K +114.37% | -40.00K +97.23% | -168.00K -216.67% | -192.00K -292.00% | -232.00K -401.30% | -267.00K -567.50% | -247.00K -47.02% | 309.00K +260.94% | -247.00K -6.47% | -275.00K -3.00% | -243.00K +1.62% | -218.00K -170.55% | -150.00K +39.27% | -150.00K +45.45% | -126.00K +48.15% | 676.00K +410.09% | -31.00K +79.33% | -16.00K +89.33% | -11.00K +91.27% | -52.00K -107.69% | -8.00K +74.19% | -1.14M -7025.00% | -1.03M -9245.45% | -1.04M -1907.69% | -592.00K -7300.00% | -1.05M +7.89% | -3.71M -- |
Other Non-Operating Income (Loss) | -32.00K -- | 26.00K -- | -54.00K -- | -385.00K -- | -536.00K -1575.00% | -1.44M -5653.85% | 144.00K +366.67% | 100.00K +125.97% | 77.00K +114.37% | -40.00K +97.23% | -168.00K -216.67% | -192.00K -292.00% | -232.00K -401.30% | -267.00K -567.50% | -247.00K -47.02% | 309.00K +260.94% | -247.00K -6.47% | -275.00K -3.00% | -243.00K +1.62% | -218.00K -170.55% | -150.00K +39.27% | -150.00K +45.45% | 0 +100.00% | 800.00K +466.97% | 0 +100.00% | -800.00K -433.33% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 126.00K -- | 124.00K -- | 31.00K -- | -784.00K -- | 11.00K -91.27% | 52.00K -58.06% | 8.00K -74.19% | 1.14M +245.41% | 1.03M +9245.45% | 1.04M +1907.69% | 592.00K +7300.00% | 1.05M -7.89% | 3.71M -- |
Pretax Income From Continuing Operations | -2.80M -- | -2.17M -- | -3.02M -- | -3.08M -- | -2.91M -3.85% | -3.73M -71.89% | -7.41M -145.53% | -3.25M -5.42% | -4.96M -70.62% | -2.70M +27.72% | -9.05M -22.12% | -4.73M -45.58% | -6.50M -31.00% | -7.69M -185.13% | 5.12M +156.54% | -2.02M +57.38% | -6.09M +6.30% | 1.04M +113.52% | -5.33M -204.18% | -1.56M +22.72% | -3.04M +50.03% | 912.00K -12.22% | -2.66M +50.09% | 4.56M +392.62% | -579.00K +80.99% | -2.01M -320.29% | -811.00K +69.51% | -2.99M -165.52% | 501.00K +186.53% | -511.00K +74.56% | -1.50M -84.71% | -2.52M +15.67% | -1.96M -490.22% | 1.41M +376.71% | -4.56M -- |
Income Tax Expense | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | 0 -- | -- -- | 0 -- | -- -- | -- -- | 247.00K -- | -- -- | 54.00K -- | -126.00K -- | 87.00K -64.78% | 74.00K -- | 66.00K +22.22% | -28.00K +77.78% | -69.00K -179.31% | 43.00K -- |
Current Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 247.00K -- | -- -- | -- -- | -- -- | 15.00K -93.93% | -- -- | -- -- | -- -- | 43.00K +186.67% | -- -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- |
Net Income | -2.80M -- | -2.17M -- | -3.02M -- | -3.08M -- | -2.91M -3.85% | -3.73M -71.89% | -7.41M -145.53% | -3.25M -5.42% | -4.96M -70.62% | -2.70M +27.72% | -9.05M -22.12% | -4.73M -45.58% | -6.50M -31.00% | -7.69M -185.13% | 5.12M +156.54% | -2.02M +57.38% | -6.09M +6.30% | 1.04M +113.52% | -5.33M -204.18% | -1.56M +22.72% | -3.04M +50.03% | 912.00K -12.22% | -2.66M +50.09% | 4.56M +392.62% | -579.00K +80.99% | -2.26M -347.37% | -811.00K +69.51% | -3.04M -166.70% | 627.00K +208.29% | -598.00K +73.49% | -1.57M -93.83% | -2.58M +15.00% | -1.93M -407.34% | 1.48M +347.99% | -4.60M -- |
Net Income Attributable to Owners of the Company | -2.80M -- | -2.17M -- | -3.02M -- | -3.08M -- | -2.91M -3.85% | -3.73M -71.89% | -7.41M -145.53% | -3.25M -5.42% | -4.96M -70.62% | -2.70M +27.72% | -9.05M -22.12% | -4.73M -45.58% | -6.50M -31.00% | -7.69M -185.13% | 5.12M +156.54% | -2.02M +57.38% | -6.09M +6.30% | 1.04M +113.52% | -5.33M -204.18% | -1.56M +22.72% | -3.04M +50.03% | 912.00K -12.22% | -2.66M +50.09% | 4.56M +392.62% | -579.00K +80.99% | -2.26M -347.37% | -811.00K +69.51% | -3.04M -166.70% | 627.00K +208.29% | -598.00K +73.49% | -1.57M -93.83% | -2.58M +15.00% | -1.93M -407.34% | 1.48M +347.99% | -4.60M -- |
Preferred Stock Dividends | 691.00K -- | 701.00K -- | 706.00K -- | 722.00K -- | 729.00K +5.50% | 22.33M +3085.73% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -3.49M -- | -2.87M -- | -3.72M -- | -3.80M -- | -3.64M -4.18% | -26.06M -807.77% | -7.41M -98.98% | -3.25M +14.59% | -4.96M -36.44% | -2.70M +89.66% | -9.05M -22.12% | -4.73M -45.58% | -6.50M -31.00% | -7.69M -185.13% | 5.12M +156.54% | -2.02M +57.38% | -6.09M +6.30% | 1.04M +113.52% | -5.33M -204.18% | -1.56M +22.72% | -3.04M +50.03% | 912.00K -12.22% | -2.66M +50.09% | 4.56M +392.62% | -579.00K +80.99% | -2.26M -347.37% | -811.00K +69.51% | -3.04M -166.70% | 627.00K +208.29% | -598.00K +73.49% | -1.57M -93.83% | -2.58M +15.00% | -1.93M -407.34% | 1.48M +347.99% | -4.60M -- |
Other Comprehensive Income | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -2.80M -- | -2.17M -- | -3.02M -- | -3.08M -- | -2.91M -3.85% | -3.73M -71.89% | -7.41M -145.53% | -3.25M -5.42% | -4.96M -70.62% | -2.70M +27.72% | -9.05M -22.12% | -4.73M -45.58% | -6.50M -31.00% | -7.69M -185.13% | 5.12M +156.54% | -2.02M +57.38% | -6.09M +6.30% | 1.04M +113.52% | -5.33M -204.18% | -1.56M +22.72% | -3.04M +50.03% | 912.00K -12.22% | -2.66M +50.09% | 4.56M +392.62% | -579.00K +80.99% | -2.26M -347.37% | -811.00K +69.51% | -3.04M -166.70% | 627.00K +208.29% | -598.00K +73.49% | -1.57M -93.83% | -2.58M +15.00% | -1.93M -407.34% | 1.48M +347.99% | -4.60M -- |
Total Comprehensive Income Attributable to Owners of the Company | -2.80M -- | -2.17M -- | -3.02M -- | -3.08M -- | -2.91M -3.85% | -3.73M -71.89% | -7.41M -145.53% | -3.25M -5.42% | -4.96M -70.62% | -2.70M +27.72% | -9.05M -22.12% | -4.73M -45.58% | -6.50M -31.00% | -7.69M -185.13% | 5.12M +156.54% | -2.02M +57.38% | -6.09M +6.30% | 1.04M +113.52% | -5.33M -204.18% | -1.56M +22.72% | -3.04M +50.03% | 9.93M +856.02% | -2.66M +50.09% | 4.56M +392.62% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Basic EPS | -1 -- | -- -- | -1.05 -- | -0.79 -- | -0.65 +35.00% | -1.48 -- | -0.42 +60.00% | -0.18 +77.22% | -0.28 +56.92% | -0.15 +89.86% | -0.5 -19.05% | -0.23 -27.78% | -0.31 -10.71% | -0.32 -113.33% | 0.21 +142.00% | -0.08 +65.22% | -0.24 +22.58% | 0.04 +112.50% | -0.21 -200.00% | -0.06 +25.00% | -0.12 +50.00% | 0.04 -- | -0.1 +52.38% | 0.18 +400.00% | -0.02 +83.33% | -0.09 -325.00% | -0.03 +70.00% | -0.12 -166.67% | 0.02 +200.00% | -0.02 +77.78% | -0.06 -100.00% | -0.1 +16.67% | -0.07 -450.00% | 0.05 +350.00% | -0.18 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.02 -- | -- -- | -0.03 -- | -0.12 -- | 0.02 +200.00% | -- -- | -0.06 -100.00% | -0.1 +16.67% | -0.07 -450.00% | -- -- | -- -- |
Diluted EPS | -1 -- | -- -- | -1.05 -- | -0.79 -- | -0.65 +35.00% | -- -- | -0.42 +60.00% | -0.18 +77.22% | -0.28 +56.92% | -- -- | -0.5 -19.05% | -0.23 -27.78% | -0.31 -10.71% | -- -- | 0.19 +138.00% | -0.08 +65.22% | -0.24 +22.58% | -- -- | -0.21 -210.53% | -0.06 +25.00% | -0.12 +50.00% | -- -- | -0.1 +52.38% | 0.18 +400.00% | -0.02 +83.33% | -- -- | -0.03 +70.00% | -0.12 -166.67% | 0.02 +200.00% | -- -- | -0.06 -100.00% | -0.1 +16.67% | -0.07 -450.00% | -- -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.02 -- | -- -- | -0.03 -- | -0.12 -- | 0.02 +200.00% | -- -- | -0.06 -100.00% | -0.1 +16.67% | -0.07 -450.00% | -- -- | -- -- |
You can ask Aime
What is Eton Pharmaceuticals's latest dividend and current dividend yield?What is Eton Pharmaceuticals's gross profit margin?What factors drove the changes in Eton Pharmaceuticals's revenue and profit?What were the key takeaways from Eton Pharmaceuticals’s earnings call?What is the revenue and EPS growth rate for Eton Pharmaceuticals year over year?What is the market's earnings forecast for Eton Pharmaceuticals next quarter?What guidance did Eton Pharmaceuticals's management provide for the next earnings period?Did Eton Pharmaceuticals beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
